S1 Ep 3: ”We are in the trenches with you”--with Guest Dr. Priya Kumthekar

An early clinical trial found that a spherical nucleic acid drug developed at Northwestern kills tumor cells in people with the fatal brain cancer glioblastoma. This is the first time a nanotherapeutic has been shown to cross the blood-brain barrier and cause cell death. Lead investigator Priya Kumthekar, MD, explains the results of the study, what's next, and why clinical trials are so vital in finding ways to combat brain cancer.